Day: July 17, 2024

Scorpio Tankers Inc. Announces That on July 30, 2024, the Company Plans to Issue Its Second Quarter 2024 Results and Have a Conference Call

MONACO, July 17, 2024 (GLOBE NEWSWIRE) — Scorpio Tankers Inc. (NYSE:STNG) (“Scorpio Tankers,” or the “Company”) announced today that on Tuesday, July 30, 2024, the Company plans to issue its second quarter 2024 earnings press release in the morning (Eastern Daylight Time) and host a conference call at 9:00 AM Eastern Daylight Time and 3:00 PM Central European Summer Time. Conference Call Information Title: Scorpio Tankers Inc. Second Quarter 2024 Conference Call Date: Tuesday, July 30, 2024 Time: 9:00 AM Eastern Daylight Time and 3:00 PM Central European Summer Time The conference call will be available over the internet, through the Scorpio Tankers Inc. website www.scorpiotankers.com and the webcast link: https://edge.media-server.com/mmc/p/uc4pks7s Participants for the live webcast should register on the website approximately...

Continue reading

Transocean Ltd. Announces Second Quarter 2024 Earnings Release Date

STEINHAUSEN, Switzerland, July 17, 2024 (GLOBE NEWSWIRE) — Transocean Ltd. (NYSE: RIG) announced today that it will report earnings for the second quarter 2024 on Wednesday, July 31, 2024. The company will conduct a teleconference to discuss the results starting at 11 a.m. EDT, 5 p.m. CEST, on Thursday, August 1, 2024. Individuals who wish to participate should dial +1 785-424-1222 approximately 15 minutes prior to the scheduled start time and refer to conference code 119567. The teleconference will be simulcast in a listen-only mode at: www.deepwater.com, by selecting Investors, News, and Webcasts. A replay of the conference call will be available after 2 p.m. EDT, 8 p.m. CEST, on August 1, 2024. The replay, which will be archived for approximately 30 days, can be accessed at +1 402-220-1119, passcode 119567. The replay also will...

Continue reading

SL Green Realty Corp. Reports Second Quarter 2024 EPS of ($0.04) Per Share; and FFO of $2.05 Per Share

Increases 2024 Earnings Guidance Financial and Operating Highlights Net loss attributable to common stockholders of $0.04 per share for the second quarter of 2024 as compared to net loss of $5.63 per share for the same period in 2023. Funds from operations, or FFO, of $2.05 per share for the second quarter of 2024, inclusive of $48.5 million, or $0.69 per share, of gains on discounted debt extinguishments at 280 Park Avenue and 719 Seventh Avenue and $1.4 million, or $0.02 per share, of positive non-cash fair value adjustments on mark-to-market derivatives. The Company reported FFO of $1.43 per share for the same period in 2023. The Company is increasing its 2024 earnings guidance range for the year ending December 31, 2024 to FFO per share of $7.45 to $7.75, an increase of $0.10 per share at the midpoint, to reflect the outperformance...

Continue reading

Royalty Pharma Declares Third Quarter 2024 Dividend

NEW YORK, July 17, 2024 (GLOBE NEWSWIRE) — The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the third quarter of 2024 of $0.21 per Class A ordinary share. The dividend will be paid on September 13, 2024, to shareholders of record at the close of business on August 16, 2024. About Royalty Pharma Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and non-profits through small and mid-cap biotechnology companies to leading global pharmaceutical companies. Royalty Pharma has assembled a portfolio of royalties which entitles it to payments based directly on the top-line sales of many of the industry’s...

Continue reading

Phase 3 VALOR Lyme Disease Trial: Valneva and Pfizer Announce Primary Vaccination Series Completion  

Participants completed primary vaccination series (3 doses) with VLA15 Primary vaccination series to be followed by a booster approximately one year after completion New York, NY and Saint-Herblain (France), July 17, 2024 – Pfizer Inc. (NYSE: PFE) and Valneva SE (Nasdaq: VALN; Euronext Paris: VLA) today announced that the participants of the Phase 3 trial “Vaccine Against Lyme for Outdoor Recreationists” (VALOR) have completed the primary vaccination series (three doses) of Lyme disease vaccine candidate VLA15. Participants will be monitored for the occurrence of Lyme disease cases until the end of the Lyme disease season in 2025.1, “The completion of the primary series of our VALOR trial is a critical step toward our goal of providing a safe and effective vaccine against Lyme disease,” said Annaliesa Anderson, Ph.D., Senior Vice President...

Continue reading

Foran Announces Upsize to Previously Announced Private Placements to C$360M

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES All amounts are in Canadian dollars unless stated otherwise VANCOUVER, British Columbia, July 17, 2024 (GLOBE NEWSWIRE) — Foran Mining Corporation (TSX: FOM) (OTCQX: FMCXF) (“Foran” or the “Company”) is pleased to announce that in connection with the proposed brokered private placement announced on July 15, 2024, the Company has entered into an amending agreement with Eight Capital, as co-lead agent and joint bookrunner with BMO Capital Markets and National Bank Financial, on behalf of a syndicate of agents (together, the “Agents”), to increase the size of the offering from $222,000,008 to $260,891,830 (the “Brokered Offering”). The Brokered Offering will now consist of (i) 57,010,327 common shares of the Company (the “Common Shares”) at an issue...

Continue reading

Benton Resources Inc. Announces C$3,600,300 “Best Efforts” Private Placement of Flow-Through Units

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES THUNDER BAY, Ontario, July 17, 2024 (GLOBE NEWSWIRE) — Benton Resources Inc. (“Benton” or the “Company”) (TSXV: BEX) is pleased to announce that it has entered into an agreement with Haywood Securities Inc. (“Haywood”), as lead agent and sole bookrunner, on its own behalf and on behalf of a syndicate of agents (together with Haywood, the “Agents”) pursuant to which the Agents have agreed to sell, on a “best efforts” private placement basis, up to 21,820,000 flow-through units (the “Flow-Through Units”) of the Company at a price of C$0.165 per Flow-Through Unit (the “Issue Price”), for gross proceeds to the Company of up to C$3,600,300 (the “Offering”). Each Flow-Through Unit will consist of one common share...

Continue reading

Nokia Corporation: Repurchase of own shares on 17.07.2024

Nokia CorporationStock Exchange Release17 July 2024 at 22:30 EEST Nokia Corporation: Repurchase of own shares on 17.07.2024 Espoo, Finland – On 17 July 2024 Nokia Corporation (LEI: 549300A0JPRWG1KI7U06) has acquired its own shares (ISIN FI0009000681) as follows: Trading venue (MIC Code) Number of shares Weighted average price / share, EUR* XHEL 440,109 3.55 CEUX – – BATE – – AQEU – – TQEX – – Total 440,109 3.55 * Rounded to two decimals On 25 January 2024, Nokia announced that its Board of Directors is initiating a share buyback program to return up to EUR 600 million of cash to shareholders in tranches over a period of two years. The first phase of the share buyback program in compliance with the Market Abuse Regulation (EU) 596/2014 (MAR), the Commission Delegated Regulation...

Continue reading

Grayscale Investments® Provides Update Related to Upcoming Corporate Action for Grayscale Ethereum Trust (Ticker: ETHE) Shareholders

STAMFORD, Conn., July 17, 2024 (GLOBE NEWSWIRE) — Grayscale Investments®, the world’s largest crypto asset manager*, offering more than 20 crypto investment products, previously announced that it has set a record date of July 18, 2024 (the “Record Date”) for the initial creation and distribution of shares of Grayscale Ethereum Mini Trust (the “ETH Trust”) to shareholders of Grayscale Ethereum Trust (Ticker: ETHE) (“ETHE”) (referred to as the “Initial Distribution”). Grayscale intends to list the ETH Trust on NYSE Arca, subject to required regulatory approvals, under the ticker symbol “ETH.” See that press release here. Today Grayscale is confirming that from and after July 18, 2024, anyone who purchases ETHE shares will not be entitled to receive ETH shares in the Initial Distribution. Additionally, Grayscale currently expects...

Continue reading

Stallion Uranium Upsizes Non-Brokered Private Placement Financing to $2.2 Million

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, July 17, 2024 (GLOBE NEWSWIRE) — Stallion Uranium Corp. (the “Company” or “Stallion”) (TSX-V: STUD; OTCQB: STLNF; FSE: FE0) is pleased to announce that due to strong investor demand, the Company has increased the maximum size of its previously announced non-brokered private placement (the “Offering”) from $1,500,000 to $2,200,000. The revised Offering consisting of units of the Company (each, a “Unit”) at a price of $0.085 per Unit, and flow-through units of the Company (each, a “FT Unit”) at a price of $0.09 per FT Unit (the “Offering”). Each Unit will consist of one common share of the Company and one-half of one transferable warrant (each whole, a “Warrant”). Each Warrant will...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.